Prevalence of AAV2.5 neutralizing antibodies in synovial fluid and serum of patients with osteoarthritis.

Autor: Abdul TY; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA.; Mary Free Bed Rehabilitation Hospital, Grand Rapids, MI, USA., Hawse GP; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA., Smith J; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA., Sellon JL; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA.; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA., Abdel MP; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA., Wells JW; The University of Queensland Diamantina Institute, Faculty of Medicine, The University of Queensland, Woolloongabba, Woolloongabba, Australia., Coenen MJ; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA., Evans CH; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA. Evans.Christopher@Mayo.edu.; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA. Evans.Christopher@Mayo.edu., De La Vega RE; Rehabilitation Medicine Research Center, Mayo Clinic, Rochester, MN, USA.; Department of Orthopedic Surgery, Mayo Clinic, Rochester, MN, USA.; Department of Cellular Biology Inspired Tissue Engineering, MERLN Institute, Maastricht University, Maastricht, the Netherlands.

Publikováno v: Gene therapy [Gene Ther] 2023 Aug; Vol. 30 (7-8), pp. 587-591. Date of Electronic Publication: 2022 Mar 09.